EUVIMEDTutustu EUVIMEDiin
Crossref

Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time

Jianhong Pan, Shijie Yu, Minggang Yin iD, Yuxuan Yang, Chongyang Duan iD

Statistics in Medicine · 2026-05 · 45 (10-12)

DOI: 10.1002/sim.70563 ↗

At a glance

Journal article in Statistics in Medicine, published online on 2026-04-24. Written by Jianhong Pan and 4 co-authors. Institution: Office of Biostatistics and Clinical Pharmacology, Center for Drug Evaluation, National Medical Products Administration, Beijing, China. Major MEDLINE topics: Randomized Controlled Trials as Topic. 38 references. Funded by: National Natural Science Foundation of China.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Sequential multiple assignment randomized trials (SMART) designs, which are used to evaluate adaptive treatment strategies (ATSs), involve multiple stages of patient randomization based on intermediate outcomes. While offering greater flexibility and personalization in treatment, these designs are often analytically complex and resource‐intensive—especially when survival outcomes are involved, given the extended follow‐up times and potential violations of proportional hazards assumptions. To address these challenges, we propose a statistical inference framework based on restricted mean survival time (RMST). RMST does not rely on the proportional‐hazards assumption and serves as a robust summary for survival data. The framework includes fixed‐ and dynamic‐weight RMST estimators, their variance–covariance structures, confidence intervals, and hypothesis tests for pairwise and global comparisons among ATSs. We also integrate interim analyses into SMART designs using RMST and develop a type I error‐control method that accommodates the lack of the independent‐increments property. Extensive simulations demonstrate good estimator performance and show that interim designs can reduce either sample size or trial duration. In summary, this study offers an efficient and practical framework for SMART trials with survival outcomes.

Subjects

MeSH terms (MEDLINE)

Randomized Controlled Trials as TopicHumansSurvival AnalysisComputer SimulationProportional Hazards ModelsModels, StatisticalResearch DesignSample Size

Author keywords

RMSTSMARTadaptive treatment strategiesinterim analysissurvival outcome

Authors and institutions

  • Office of Biostatistics and Clinical Pharmacology, Center for Drug Evaluation, National Medical Products Administration, Beijing, China.
  • State Key Laboratory of Multi-Organ Injury Prevention and Treatment, Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.

ORCID profiles: Minggang Yin, Chongyang Duan

Funding

  • National Natural Science Foundation of China

Cite

APA

Pan, J., Yu, S., Yin, M., Yang, Y., & Duan, C. (2026). Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time. Statistics in Medicine, 45(10-12). https://doi.org/10.1002/sim.70563

Vancouver

Pan J, Yu S, Yin M, Yang Y, Duan C. Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time. Statistics in Medicine. 2026;45(10-12). doi:10.1002/sim.70563

BibTeX
@article{Pan2026,
  author = {Pan, Jianhong and Yu, Shijie and Yin, Minggang and Yang, Yuxuan and Duan, Chongyang},
  title = {Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {10-12},
  doi = {10.1002/sim.70563}
}
Start for free →